SCHEMBL628811

SCHEMBL628811

COC(=O)c1ccc(I)cc1-c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.46
SLC6A4 P31645 3/20 0.46
SLC6A2 P23975 1/20 0.46
NR4A2 P43354 1/20 0.42
MAPT P10636 3/20 0.41
KMT2A Q03164 3/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 2/20 0.41
MITF O75030 1/20 0.41
HTT P42858 1/20 0.41
MAPK10 P53779 1/20 0.41
PTK2B Q14289 1/20 0.41
NCOA1 Q15788 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
LMNA P02545 1/20 0.41
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2267132 0.84 SLC6A3 (0.51) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL7570354 0.83 KDM4E (0.53) SLC6A3SLC6A4SLC6A2MAPTTSHR
SCHEMBL22256464 0.83 MAPT (0.47) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL9549 0.82 SLC6A3 (0.57) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL6780722 0.82 SLC6A3 (0.42) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL7915060 0.82 GAA (0.55) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL6777619 0.81 SLC6A3 (0.50) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL6625716 0.81 SLC6A3 (0.43) SLC6A3SLC6A4SLC6A2NR4A2MAPT
SCHEMBL6775688 0.81 SLC6A3 (0.49) SLC6A3SLC6A4SLC6A2MAPTKMT2A
SCHEMBL7576345 0.81 TTR (0.45) SLC6A3SLC6A4SLC6A2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0986384-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2012-02-22 EP disclosed
EP-0986384-A4 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2004-09-15 EP disclosed
US-6693123-B2 (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA UNIVERSITY OF PITTSBURGH 2004-02-17 US disclosed
US-20020193596-A1 Inhibitors of protein isoprenyl transferases UNIVERSITY OF PITTSBURGH (US) 2002-12-19 US disclosed
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed
EP-0986384-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 2000-03-22 EP disclosed
WO-1998050029-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193596-A1 Inhibitors of protein isoprenyl transferases LANCL1, FNTB, DHCR7 SLC6A3 2958/4885SLC6A4 3320/4885SLC6A2 2136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.